DJIA 17,449.66 62.45 0.36%
NASDAQ 4,728.91 47.41 1.01%
S&P 500 2,037.57 8.02 0.40%
market minute promo

VIVUS, Inc. (NASDAQ: VVUS)



company name or ticker

Contrave Scripts Continue Increases For Orexigen

Newly Approved Weight Loss Method Works by Tricking Your Brain

What's the best way to lose weight? One company thinks it's simple: don't get hungry.

Arena's Belviq Prescriptions Fall: More Publicity Is Needed

Novo Nordisk Receives Positive Opinion In Europe On Obesity Treatment

Benzinga's Top #PreMarket Gainers

Arena Pharmaceuticals to Raise Fund Via Share Issuance - Analyst Blog

The 52-Week Low Club for Thursday

Vivus (VVUS) Weak On High Volume

Forget Pills! Could This Device Put an End to Obesity in America?

We've witnessed three oral anti-obesity meds approved since mid-2012, but this newly approved device could be a game-changer.

5 Obesity Stocks Investors Are Watching

See More Articles...